U.S. Infrastructure Stock News

NasdaqCM:ASTH
NasdaqCM:ASTHHealthcare

Astrana Health (ASTH) Shares Just Moved, So What Is Going On?

Astrana Health (ASTH) drew investor attention after releasing second quarter 2026 results and fresh guidance, alongside plans for further tuck in acquisitions in its Care Delivery expansion markets. See our latest analysis for Astrana Health. Astrana Health's recent earnings beat and updated 2026 guidance appear to be feeding into a strong year to date share price return of 57.61%. However, the 30 day share price return is down 11.55% and the 5 year total shareholder return is down 44.72%,...
NasdaqGM:QCRH
NasdaqGM:QCRHBanks

How Investors Are Reacting To QCR Holdings (QCRH) Record EPS on Diversified, Cost-Efficient Revenue Growth

In the past quarter, QCR Holdings reported revenue growth of 13.4% year on year, beating analyst expectations, while strong loan production, a rebound in capital markets revenue, and wealth management contributions helped deliver record GAAP EPS alongside lower-than-anticipated noninterest expenses. This performance highlights how QCR Holdings’ diversified banking and fee-based businesses can support earnings resilience when multiple segments contribute simultaneously to revenue and cost...
NYSE:VIRT
NYSE:VIRTCapital Markets

Could Virtu Financial’s New Buyback Algorithms Redefine Its Competitive Moat and Earnings Mix (VIRT)?

Virtu Financial recently launched notional order execution capabilities for 10b-18 corporate buyback programs, enabling clients to execute repurchases based on specific dollar amounts for tighter budget control and flexible commission treatment. Truist Bank’s internal analysis indicated that Virtu’s new notional execution outperformed a competing provider on benchmark quality and total notional value executed, highlighting the product’s differentiation in a niche market. We’ll now examine...
NasdaqGS:AMSC
NasdaqGS:AMSCElectrical

American Superconductor (AMSC) Stock Stays Cheap On Value Even After A 254% Run

American Superconductor stock has retreated 39.9% over the past year, yet an intrinsic value estimate based on a Discounted Cash Flow (DCF) model currently points to around 12.5% upside from the recent share price of US$32.13. With market multiples also screening the stock as undervalued, investors are weighing whether the recent pullback has moved the price below what the cash flow outlook implies. Over the last 3 years, American Superconductor has returned 254.2%. This means long term...
NYSE:MET
NYSE:METInsurance

MetLife Stock And Other Insurers Gaining From Higher Long Term Treasury Yields

With 30 year and 10 year Treasury yields pushing toward levels not seen in decades, the bond market is quietly rewriting the playbook for investors. Higher long term rates can pressure many stocks, yet they can also reshape the income potential and risk profile of others. This article looks at how that backdrop ties into three U.S. life insurers and annuity providers exposed to these yield moves, and what that could mean for your watchlist. The three stocks covered below are only a starting...
NYSE:RDW
NYSE:RDWAerospace & Defense

Aerospace And Defense Stocks To Watch For Long Term Contract Exposure

Global bond markets are under pressure as 10 year yields in major regions move to multi year highs, reflecting concerns about inflation and fiscal strain. When borrowing costs rise, investors often pay closer attention to companies tied to long term government and defense contracts. This article looks at three stocks from the Aerospace And Defense screener that could help you explore this theme in a more targeted way. The stocks covered below are just a starting sample, and the full screen...
NasdaqGS:PCTY
NasdaqGS:PCTYProfessional Services

What Is Drawing Attention To Paylocity Holding (PCTY)?

Why Paylocity’s latest earnings and partnerships matter for investors Paylocity Holding (PCTY) has been in focus after reporting fourth quarter and full year 2026 earnings alongside new partnerships that tie its human capital platform more tightly into AI driven recruiting tools. The company’s recent collaboration with HireQuotient and RocketReach links Paylocity’s cloud based HR, payroll and spend management suite to data powered sourcing and screening. This lets customers automate parts of...
NasdaqGS:STEP
NasdaqGS:STEPCapital Markets

StepStone Group (STEP) Following Q1 Results Is The Rebound A Bargain Or Priced In

StepStone Group (STEP) is back in focus after reporting first quarter results for the period ended June 30, 2026. The company posted higher revenue alongside a wider net loss that may raise fresh questions for investors. See our latest analysis for StepStone Group. Despite the wider loss in the latest quarter, StepStone Group’s share price has risen 10.86% over the past month, although the share price is still down 27.52% year to date and the 1 year total shareholder return is down 16.18%,...
NasdaqGS:WMT
NasdaqGS:WMTConsumer Retailing

Walmart (WMT) Stock Looks Fully Valued After Its Big Run

Walmart stock has delivered a strong 142.1% total return over the past five years, while the latest valuation work using a Discounted Cash Flow (DCF) approach suggests the shares trade at a premium to that intrinsic value estimate. Over five years, Walmart has returned 142.1%, which puts recent gains under the spotlight as investors assess how much future cash flow is already reflected in the price. Growth expectations around e-commerce, advertising and automation partnerships such as the...
NYSE:LLY
NYSE:LLYPharmaceuticals

Eli Lilly (LLY) Stock Looks Undervalued Relative To Fair Value

Eli Lilly stock has delivered a very large 5 year return while valuation checks now give a more mixed read. The Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside compared with a share price that already embeds high expectations. Eli Lilly has returned about 362.3% over 5 years, which puts extra focus on whether current holders are paying a premium for that track record. Expectations around long term demand for its obesity and diabetes treatments can support...
NasdaqGS:DXCM
NasdaqGS:DXCMMedical Equipment

The Bull Case For DexCom (DXCM) Could Change Following Expanded Type 2 CGM Reimbursement Access - Learn Why

Earlier this year, DexCom highlighted that expanded insurance reimbursement now gives its continuous glucose monitoring systems access to a large group of type 2 non-insulin diabetes patients, while recent Q2 clinical data and product updates underscored the medical benefits of broader CGM use. This combination of wider coverage and strong evidence base is reshaping expectations for DexCom’s long-term demand profile and business mix, even as competition and pricing uncertainties remain...
NasdaqGM:VERA
NasdaqGM:VERABiotechs

What Vera Therapeutics (VERA)'s Widening Losses and Cash Burn Mean For Shareholders

Vera Therapeutics, Inc. reported past second quarter 2026 results showing a net loss of US$109.47 million, up from US$76.53 million a year earlier, with basic loss per share from continuing operations widening to US$1.52 from US$1.20. For the first half of 2026, the company’s net loss rose to US$230.51 million from US$128.23 million, highlighting a materially higher cash burn and pressure on per-share results at this stage of its development. Next, we will examine how this widening net loss...
NasdaqGM:ARDX
NasdaqGM:ARDXBiotechs

Exploring 3 High Growth Tech Stocks In The US Market

Over the last 7 days, the United States market has remained flat, but it is up 19% over the past year with earnings expected to grow by 17% per annum over the next few years. In this context of steady growth and optimistic projections, identifying high-growth tech stocks involves looking for companies that demonstrate strong innovation and potential for expansion in a dynamic industry landscape.
NasdaqCM:SWMR
NasdaqCM:SWMRAerospace & Defense

3 Stocks Estimated To Be Undervalued By 10.8% To 35.4%

In the last week, the United States market has stayed flat, yet it has experienced a notable 19% increase over the past year, with earnings expected to grow by 17% annually in the coming years. In this context of steady growth and positive earnings outlooks, identifying undervalued stocks can present opportunities for investors to capitalize on potential market inefficiencies.
NasdaqGS:PGC
NasdaqGS:PGCBanks

3 Growth Companies With Insider Ownership As High As 17%

Over the last 7 days, the United States market has remained flat, yet it is up 19% over the past year with earnings forecasted to grow by 17% annually. In this environment, growth companies with high insider ownership can be appealing as they often align management's interests with those of shareholders, potentially driving long-term value.
NYSE:NPWR
NYSE:NPWRElectrical

Top Penny Stocks To Watch In August 2026

In the last week, the market has stayed flat, but it is up 19% over the past year with earnings expected to grow by 17% annually. For investors seeking opportunities beyond traditional stocks, penny stocks — a term that may seem outdated yet remains relevant — can provide access to smaller or less-established companies with potential for growth. By focusing on those with robust financials and a clear growth trajectory, investors might uncover promising prospects within this niche segment of...
NasdaqGS:CSX
NasdaqGS:CSXTransportation

CSX Stock And 2 Rail Names Riding Canada US Auto Trade Shifts

Tariffs on Canadian autos and the threat of wider counter moves are reshaping how vehicles and parts move across the border, and that puts freight routes and rail lines under the spotlight. Investors watching this Canada and U.S. auto trade story may see both pressure and possibility as supply chains adjust. This article walks through three stocks that appear exposed to this news and explains why the market is paying attention now. The three stocks below are just a starting sample, and the...
NYSE:VRTS
NYSE:VRTSCapital Markets

Will Shifting Zevenbergen’s High-Growth Funds Into ETFs Redefine Virtus Investment Partners’ (VRTS) Innovation Story?

Virtus Investment Partners has converted the Zevenbergen Growth Fund and Zevenbergen Genea Fund into the actively managed Virtus Zevenbergen Innovative Growth ETF (ZINN) and Virtus Zevenbergen Discovery Growth ETF (ZDIS), expanding its ETF lineup while retaining Zevenbergen Capital Investments’ high-growth equity strategies. This move shifts Zevenbergen’s growth approach into an ETF structure that offers intraday trading, full portfolio transparency, and potential tax efficiencies for...
NasdaqGS:UTHR
NasdaqGS:UTHRBiotechs

United Therapeutics (UTHR) Could Be 24% Undervalued On TETON PPF Enrollment Progress

Why the TETON-PPF milestone matters for United Therapeutics stock United Therapeutics (UTHR) has reached full enrollment in its 754 patient TETON-PPF phase 3 trial of nebulized Tyvaso for progressive pulmonary fibrosis, a key step toward potential label expansion. This milestone gives you a clearer timetable for the next catalyst. Topline data are expected in the second half of 2027, and the company has flagged the study as a basis for a possible supplemental FDA filing. See our latest...
NYSE:CUBE
NYSE:CUBESpecialized REITs

CubeSmart (CUBE) Is Back In Focus, What Is Catching Investors’ Attention?

Fresh commentary on CubeSmart (CUBE) has put its dividend profile, growth potential, and exposure to migration trends in focus as investors reassess self storage REITs and look for income opportunities in the sector. See our latest analysis for CubeSmart. CubeSmart’s share price has climbed 16.21% year to date to US$41.14, with a 90 day share price return of 5.60% and a 1 year total shareholder return of 11.53%. This points to gradually improving momentum as investors react to commentary...
NasdaqGS:IPAR
NasdaqGS:IPARPersonal Products

Interparfums (IPAR) Earnings And Guidance Put Fair Value Back In Focus

Interparfums (IPAR) is back on investors’ radar after affirming a regular quarterly dividend of $0.80 per share, updating its buyback activity, and reporting second quarter earnings alongside full year 2026 guidance. See our latest analysis for Interparfums. Interparfums’ recent dividend affirmation, buyback update, and earnings release come after a period where the share price has risen 30.8% year to date, while the 1 year total shareholder return is 2.3%. Near term momentum has been strong,...
NasdaqGS:WBTN
NasdaqGS:WBTNInteractive Media and Services

WEBTOON Entertainment (WBTN) Is Down 10.8% After Weak Q3 Revenue Outlook And Wider Losses – Has The Bull Case Changed?

WEBTOON Entertainment Inc. recently reported second-quarter 2026 results showing sales of US$338.47 million and a wider net loss of US$15.25 million, and issued third-quarter guidance for constant-currency revenue growth of 0.7%–3.3% to US$358–US$368 million. Management pointed to softness in Japan and heavier marketing spend alongside progress in AI features and IP adaptations, highlighting a tension between near-term profit pressure and longer-term efforts to deepen engagement and...
NYSEAM:HYLN
NYSEAM:HYLNElectrical

Ardelyx Stock And Two Penny Shares Worth A Closer Look

With global bond yields climbing as central banks keep a firm focus on inflation, many investors are rethinking where to take risk. That is where a Financially Fit Penny Stocks screener becomes interesting. It filters for low-priced stocks backed by healthier balance sheets, which can matter when borrowing costs are higher. This article walks through 3 screened stocks that aim to combine affordability with financial discipline. The three stocks highlighted below are a small sample. The full...
NYSE:PLGO
NYSE:PLGOInsurance

How Investors Are Reacting To Pelagos Insurance Capital (PLGO) Profit Return and One‑Third Share Buyback

In the past quarter, Pelagos Insurance Capital Limited reported second‑quarter 2026 revenue of US$650 million and net income of US$44.4 million, with basic earnings per share from continuing operations of US$0.53. For the first half of 2026 the company moved from a loss to a profit and completed a large-scale buyback that has retired about one‑third of its shares, pointing to an assertive capital return approach. Next, we will examine how Pelagos’s sharp earnings turnaround and extensive...